Tg Therapeutics (TGTX) Change in Inventory (2023 - 2026)

Tg Therapeutics' Change in Inventory history runs 4 years deep, the most recent figure standing at $13.3 million for Q1 2026.

• In Q1 2026, Change in Inventory fell 71.33% year-over-year to $13.3 million; the TTM figure through Mar 2026 stood at $422000.0 (down 99.45% YoY), while the FY2025 annual figure was $33.5 million, down 49.96% from the prior year.
• Change in Inventory for Q1 2026 stood at $13.3 million, up from -$563000.0 in the prior quarter.
• The five-year high for Change in Inventory was $46.3 million in Q1 2025, with the low at -$8.7 million in Q3 2025.
• The 4-year median for Change in Inventory is $2.6 million (2024), against an average of $11.6 million.
• The sharpest annual moves came in 2024 and 2025: Change in Inventory jumped 350.78% in 2024, then tumbled 442.32% in 2025.
• Tg Therapeutics' Change in Inventory stood at $5.5 million in 2023, then surged by 350.78% to $24.8 million in 2024, then tumbled by 102.27% to -$563000.0 in 2025, then surged by 2457.9% to $13.3 million in 2026.
• Business Quant data shows TGTX's Change in Inventory at $13.3 million in Q1 2026, -$563000.0 in Q4 2025, and -$8.7 million in Q3 2025.